Progressive Multifocal Leukoencephalopathy (PML) With Anti-CD20 and Other Monoclonal Antibody (mAb) Therapies in Multiple Sclerosis

被引:0
|
作者
Sharma, Kanika [1 ]
Srivastava, Samiksha [2 ]
Jena, Anek [3 ]
Kakara, Mihir [4 ]
Sriwastava, Shitiz [5 ]
Daimee, Maha [6 ]
Xu, Jian [7 ]
机构
[1] West Virginia Univ, Rockefeller Neurosci Inst, Dept Neurol, Neurol, Morgantown, WV USA
[2] Sinai Grace Hosp DMC, Neurol, Detroit, MI USA
[3] Calcutta Med Coll, Neurol, Kolkata, India
[4] Univ Penn, Perelman Sch Med, Dept Neurol, Neurol, Philadelphia, PA USA
[5] West Virginia Clin & Translat Sci Inst, Neurol, Morgantown, WV USA
[6] Beaumont Hosp, Neurol, Dublin, Ireland
[7] Henry Ford Hosp, Neurol, Detroit, MI USA
关键词
D O I
10.1212/WNL.0000000000202034
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P8-3.016
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Progressive multifocal leukoencephalopathy in anti-CD20 and other monoclonal antibody (mAb) therapies used in multiple sclerosis: A review
    Sharma, Kanika
    Tolaymat, Sarah
    Yu, Hongxuyang
    Elkhooly, Mahmoud
    Jaiswal, Shruti
    Jena, Anek
    Kakara, Mihir
    Sriwastava, Shitiz
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 443
  • [2] Escalation to Anti-CD20 Treatment for Multiple Sclerosis Following Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
    Wolf, Andrew B.
    Corboy, John R.
    [J]. NEUROLOGY-CLINICAL PRACTICE, 2024, 14 (05)
  • [3] Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis
    Finn Sellebjerg
    Morten Blinkenberg
    Per Soelberg Sorensen
    [J]. CNS Drugs, 2020, 34 : 269 - 280
  • [4] Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis
    Sellebjerg, Finn
    Blinkenberg, Morten
    Sorensen, Per Soelberg
    [J]. CNS DRUGS, 2020, 34 (03) : 269 - 280
  • [5] Anti-CD20 monoclonal antibodies in multiple sclerosis
    Moreno Torres, Irene
    Garcia-Merino, Antonio
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (04) : 359 - 371
  • [6] Anti-CD20 antibody wows in multiple sclerosis
    Sheridan, Cormac
    [J]. NATURE BIOTECHNOLOGY, 2015, 33 (12) : 1215 - 1216
  • [7] Anti-CD20 antibody wows in multiple sclerosis
    Cormac Sheridan
    [J]. Nature Biotechnology, 2015, 33 : 1215 - 1216
  • [8] Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: What do we know after 20 years of rituximab
    Focosi, Daniele
    Tuccori, Marco
    Maggi, Fabrizio
    [J]. REVIEWS IN MEDICAL VIROLOGY, 2019, 29 (06)
  • [9] The anti-JC virus antibody index in CSF for diagnosis of progressive multifocal leukoencephalopathy (PML) in patients with multiple sclerosis
    Warnke, C.
    Markwerth, P.
    Pawlita, M.
    Hermsen, D.
    Hartung, H-P.
    Stettner, M.
    Dehmel, T.
    Kieseier, B.
    Adams, O.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 57 - 57
  • [10] Anti-CD20 monoclonal antibody in multiple sclerosis therapy: the results of phase 3 clinical studies on relapsing and primary progressive multiple sclerosis
    Maciejowski, Maciej
    [J]. AKTUALNOSCI NEUROLOGICZNE, 2015, 15 (03): : 150 - 154